Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
from Dementia Big http://ift.tt/2htHYYD via alcoholic dementia
http://ift.tt/2iBMXTk
No comments:
Post a Comment